– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 – –Total… – Reports $156 to $160 Million in Preliminary* ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the… BOSTON–(BUSINESS WIRE)–...
IDEAYA Biosciences (IDYA) provided a business update including an overview of key corporate objectives for 2026. 2026 Corporate Objectives: Daro… IDEAYA Biosciences (IDYA) provided a business up...
Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance… Preliminary 4Q 2025 VYJUVEK net revenu...
– Rapidly transforming into a leading global biopharma company… COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and...
Carter’s, Inc. (NYSE:CRI), North America’s largest and most-enduring apparel company exclusively for babies and young children, today announced preliminary n… ATLANTA–(BUSINESS WIRE)–...
Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) (“Altius”) is pleased to update its Project Generation (“PG”) business activities and its public junior… ST. JOHN’S, Newfoundland–(BUS...
MannKind Provides Business Updates and 2026 Growth Drivers… DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmace...
– Invested $269 Million in Convenience and Automotive Retail Assets – – Introduces 2026 Earnings Guidance – NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) –… – Inve...
– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM® Net Revenue Expected in the Range of $190 Million to $200… – Product Revenues, Net Expected in the Ra...
